Finance

ZyVersa Therapeutics, a clinical stage specialty biopharmaceutical company specializing in the development of first-in-class drugs for the treatment of inflammatory and renal diseases, has announced

Monopar Therapeutics, a clinical-stage biopharmaceutical company dedicated to advancing proprietary therapeutics aimed at enhancing the longevity and quality of life for cancer patients, is set

CVS Health reported impressive third-quarter (Q3) results, surpassing Wall Street’s estimates. Despite facing higher-than-projected medical costs in its health insurance arm, the company’s strong performance